Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -3.85 |
| peg ratio | 0.28 |
| price to book ratio | -3.04 |
| price to sales ratio | 324.15 |
| enterprise value multiple | -4.15 |
| price fair value | -3.04 |
profitability ratios | |
|---|---|
| gross profit margin | -24.37% |
| operating profit margin | -4900.23% |
| pretax profit margin | -8018.55% |
| net profit margin | -8016.83% |
| return on assets | -161.23% |
| return on equity | 86.39% |
| return on capital employed | -118.34% |
liquidity ratio | |
|---|---|
| current ratio | 2.68 |
| quick ratio | 2.64 |
| cash ratio | 1.84 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 78.37 |
| operating cycle | 286.21 |
| days of payables outstanding | 398.06 |
| cash conversion cycle | -111.85 |
| receivables turnover | 1.76 |
| payables turnover | 0.92 |
| inventory turnover | 4.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.04 |
| debt equity ratio | -1.00 |
| long term debt to capitalization | -15.52 |
| total debt to capitalization | -594.33 |
| interest coverage | -2.41 |
| cash flow to debt ratio | -0.57 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.62 |
| cash per share | 0.19 |
| operating cash flow per share | -0.61 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -0.57 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -33.09 |
Frequently Asked Questions
ImmunityBio, Inc. (IBRX) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ImmunityBio, Inc. (NASDAQ:IBRX)'s trailing twelve months ROE is 86.39%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ImmunityBio, Inc. (IBRX) currently has a ROA of -161.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
IBRX reported a profit margin of -8016.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.68 in the most recent quarter. The quick ratio stood at 2.64, with a Debt/Eq ratio of -1.00.